Ibrexafungerp Citrate-impurities | Pharmaffiliates

Ibrexafungerp Citrate

Ibrexafungerp, sold under the brand name Brexafemme, is an antifungal medication used to treat vulvovaginal candidiasis (VVC) (vaginal yeast infection). Reference standards of Ibrexafungerp Citrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Ibrexafungerp Citrate - API Standards 
    [catalogue_number] => PA 09 1320000
    [category_ids] => ,78,70,82,
    [chemical_name] => 
    [weight] => 922.17
    [form] => C50H75N5O11
    [cas] => 1965291-08-0
    [pslug] => 1965291-08-0-ibrexafungerp-citrate-api-pa091320000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 09 1320000

Ibrexafungerp Citrate - API Standards


  • Catalogue No.:PA 09 1320000

  • CAS :

    1965291-08-0

  • Molecular Formula : C50H75N5O11

  • Molecular Weight : 922.17